CAN
Asset Logo

Cann Group Limited

πŸ‡¦πŸ‡Ί ASX

πŸ“¦ LOGISTICS

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-18.22%
Annual Growth

5 years average annual growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

62
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Cann Group Ltd. engages in the cultivation of medicinal cannabis and further processing into manufactured medicinal cannabis products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The company operates through cultivation of the medicinal cannabis segment. The firm supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. The company also owns Satipharm and its patent-protected capsule technology. The firm's research, cultivation, and good manufacturing practices (GMP) manufacturing facilities are in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.

πŸ“ View Factsheet

πŸ“ˆ Performance

Price History

-85.33%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.04

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in CAN

62

πŸ“Š Total Capital Earnings

$35K

πŸ”ƒ Average investment frequency

46 weeks

πŸ’΅ Average investment amount

$873

⏰ Last time a customer invested in CAN

19 days
CAN investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

31%

50k - 100k

35%

Less than 50k

31%
πŸ‘Ά Age of investors

18 - 25

26 - 34

31%

35 - 90

69%
πŸ™‹ Legal gender of investors

Female

52%

Male

48%

Pearlers who invest in CAN also invest in...

Cann Group Limited

CANN

Cann Group Ltd. operates research and development and cultivation facilities to grow medicinal cannabis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The firm supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. The company also owns Satipharm and its patent-protected capsule technology. The firm's research, cultivation and good manufacturing practices (GMP) manufacturing facilities are located in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.

Find Out More

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

4.32%

πŸ“Š Share price

$105.00 AUD

⛳️ DIVERSIFIED

πŸ’Έ FINANCIALS

🧱 MATERIALS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

13.28%

πŸ“Š Share price

$136.19 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ€– TECHNOLOGY

⛳️ DIVERSIFIED

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

4.09%

πŸ“Š Share price

$69.21 AUD

⛳️ DIVERSIFIED

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

πŸ™Œ Performance (5Yr p.a)

19.66%

πŸ“Š Share price

$61.48 AUD

πŸ‡ΊπŸ‡Έ UNITED STATES

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

Cann Group Ltd. operates research and development and cultivation facilities to grow medicinal cannabis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The firm supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. The company also owns Satipharm and its patent-protected capsule technology. The firm's research, cultivation and good manufacturing practices (GMP) manufacturing facilities are located in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.

CAQ Holdings Ltd. engages in property development and jewelry trading. The company is headquartered in Perth, Western Australia. The company went IPO on 2005-07-25. The firm has two lines of business being property development and retail trading. Its Haikou Free Trade Zone project (the Haikou Project) is located in the Haikou Integrated Free Trade Zone, within the Laocheng economic development zone, Haikou Master Planning, and is adjacent to Macun Port. The Haikou project includes approximately 44,020 square meters of properties and consists of several multi-story buildings, containing factories, warehouses, a commercial/administration building, and a retail complex. The company is also engaged in the processing, exhibition and sale of mainly diamonds and jewelry together with other commodities. Its subsidiaries include CAQ Diamond Network Limited, Rayport Limited, Peace Base Holdings Limited, Actual Winner Limited and others.

πŸ“Š Share price

$0.01 AUD

🏠 REAL ESTATE

Clime Capital Ltd is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-02-03. Clime Capital Limited is an Australia-based investment company. The firm is primarily an investor in securities listed on the Australian Securities Exchange (ASX). The principal activity of the Company is investing in domestic securities and unlisted unit trusts. Its focus is to deliver above market returns and fully franked dividend yields higher than those that can be achieved by investing in the ASX or an associated index. The company is designed for investors who are seeking long-term capital preservation when measured against inflation, access to quarterly income with the added benefit of franking credits, the expertise of a professional investment manager, and having a minimum of five years to invest. Its asset allocation includes Australian equities large cap, Australian Dollar (AUD) cash and equivalents, Australian income securities and Australian equities small cap. The firm's investment manager is Clime Asset Management Pty Limited.

πŸ™Œ Performance (5Yr p.a)

-2.62%

πŸ“Š Share price

$0.80 AUD

πŸ’° HIGH DIVIDEND

Clime Capital Ltd is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-02-03. Clime Capital Limited is an Australia-based investment company. The firm is primarily an investor in securities listed on the Australian Securities Exchange (ASX). The principal activity of the Company is investing in domestic securities and unlisted unit trusts. Its focus is to deliver above market returns and fully franked dividend yields higher than those that can be achieved by investing in the ASX or an associated index. The company is designed for investors who are seeking long-term capital preservation when measured against inflation, access to quarterly income with the added benefit of franking credits, the expertise of a professional investment manager, and having a minimum of five years to invest. Its asset allocation includes Australian equities large cap, Australian Dollar (AUD) cash and equivalents, Australian income securities and Australian equities small cap. The firm's investment manager is Clime Asset Management Pty Limited.

πŸ™Œ Performance (5Yr p.a)

-0.06%

πŸ“Š Share price

$1.00 AUD
Compare
Add to watchlist